Filing Details

Accession Number:
0001209191-16-122617
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 16:32:31
Reporting Period:
2016-05-20
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 16:32:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478831 Jeffrey Stein 6310 Nancy Ridge Drive
Suite 101
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-20 4,310 $11.51 203,697 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,100 Direct
Footnotes
  1. Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $11.46 to $11.54.